1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. NEUROCRINE BIOSCIENCES, INC.
Neurocrine Biosciences, Inc.
XNAS: NBIX

Neurocrine Biosciences Inc Live Stock Price Today, Share Analysis and Chart

Await Turnaround
about

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions su...

Read More
134.07 2.29 (1.74%)
1.2M
XNAS Volume

XNAS 04 May, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Neurocrine Biosciences Inc is on 05 May 2026 for the purpose of Neurocrine Biosciences Inc First Quarter Earnings Results for 2026 See details
Durability score
Low Financial Strength
33.3 / 100
Valuation Score
Mid Valuation
42.3 / 100
Momentum Score
Technically Neutral
51.2 / 100
Await Turnaround These stocks have poor financials and average valuation and momentum. Investors should be cautious about these stocks View Similar Embed DVM
Analyst Price Target
186
1Yr Price target upside is 38%
27 analysts

19

S

9

W

1

O

3

T

SWOT Analysis

Neurocrine Biosciences Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..